Adage Capital Partners Gp, L.L.C. Merck & Co., Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

  • $51 Billion
  • Q1 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,375,591 shares of MRK stock, worth $418 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
3,375,591
Previous 1,895,823 78.05%
Holding current value
$418 Million
Previous $207 Million 115.5%
% of portfolio
0.87%
Previous 0.44%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$113.24 - $131.95 $168 Million - $195 Million
1,479,768 Added 78.05%
3,375,591 $445 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $96.5 Million - $105 Million
-963,016 Reduced 33.69%
1,895,823 $207 Million
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $19,869 - $22,065
-193 Reduced 0.01%
2,858,839 $294 Million
Q2 2023

Aug 14, 2023
BUY
$108.61 - $118.38 $28.1 Million - $30.6 Million
258,407 Added 9.94%
2,859,032 $330 Million
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $12.2 Million - $13.6 Million
-118,700 Reduced 4.37%
2,600,625 $277 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $35.3 Million - $45.3 Million
404,264 Added 17.46%
2,719,325 $302 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $67.8 Million - $76.1 Million
801,685 Added 52.97%
2,315,061 $199 Million
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $25.9 Million - $29.4 Million
310,700 Added 25.83%
1,513,376 $138 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $41.1 Million - $46.1 Million
-559,000 Reduced 31.73%
1,202,676 $98.7 Million
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $2.85 Million - $3.57 Million
-39,430 Reduced 2.19%
1,761,676 $135 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $21.2 Million - $23.3 Million
296,000 Added 19.67%
1,801,106 $135 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $130 Million - $144 Million
-1,846,200 Reduced 55.09%
1,505,106 $117 Million
Q1 2021

May 17, 2021
BUY
$68.86 - $81.11 $159 Million - $187 Million
2,302,300 Added 219.47%
3,351,306 $258 Million
Q4 2020

Feb 16, 2021
SELL
$71.77 - $79.65 $90.3 Million - $100 Million
-1,257,500 Reduced 54.52%
1,049,006 $85.8 Million
Q3 2020

Nov 16, 2020
BUY
$73.18 - $82.95 $5.36 Million - $6.08 Million
73,300 Added 3.28%
2,306,506 $191 Million
Q2 2020

Aug 14, 2020
SELL
$70.42 - $80.13 $41.9 Million - $47.7 Million
-594,700 Reduced 21.03%
2,233,206 $173 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $40.7 Million - $56.4 Million
-642,685 Reduced 18.52%
2,827,906 $218 Million
Q4 2019

Feb 14, 2020
SELL
$77.58 - $87.54 $14.6 Million - $16.4 Million
-187,800 Reduced 5.13%
3,470,591 $316 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $2.18 Million - $2.38 Million
-28,700 Reduced 0.78%
3,658,391 $308 Million
Q2 2019

Aug 14, 2019
SELL
$69.84 - $81.59 $38.9 Million - $45.5 Million
-557,102 Reduced 13.13%
3,687,091 $309 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $79.4 Million - $90.6 Million
-1,141,600 Reduced 21.2%
4,244,193 $353 Million
Q4 2018

Feb 14, 2019
SELL
$65.24 - $75.71 $73.5 Million - $85.3 Million
-1,126,140 Reduced 17.29%
5,385,793 $412 Million
Q3 2018

Nov 14, 2018
SELL
$57.69 - $67.84 $3.54 Million - $4.16 Million
-61,300 Reduced 0.93%
6,511,933 $462 Million
Q2 2018

Aug 14, 2018
BUY
$50.83 - $59.72 $168 Million - $198 Million
3,312,140 Added 101.57%
6,573,233 $399 Million
Q1 2018

May 15, 2018
SELL
$50.96 - $59.23 $36.8 Million - $42.7 Million
-721,600 Reduced 18.12%
3,261,093 $178 Million
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $29.7 Million - $35.4 Million
-574,600 Reduced 12.61%
3,982,693 $224 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $267 Million - $288 Million
4,557,293
4,557,293 $292 Million

Others Institutions Holding MRK

# of Institutions
3,766
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email